Yikon Genomics, a global leader in precision genetics, has officially expanded into Malaysia with the launch of its state-of-the-art genetic testing laboratory in Kuala Lumpur, marking a significant milestone in the company’s Asia Pacific growth strategy. The new facility underscores Yikon’s commitment to making advanced genetic testing and preventive healthcare accessible, affordable, and transformative across the region. At the launch event, Dr. Sijia Lu, CEO and Founder of Yikon Genomics, reflected on the company’s journey from pioneering reproductive genetics to advancing preventive medicine, hereditary cancer screening, and population health initiatives. “We started with reproductive genetics because life begins at its most delicate stage, the embryo,” Dr. Lu said, highlighting how Yikon’s technology detects even the smallest genetic variations with precision, now applied to lifelong wellness and preventive care.
The Kuala Lumpur laboratory serves as a multifunctional regional hub, supporting scientific excellence, workforce development, and clinical collaboration. Dr. David Wong, Lab Manager of Yikon Genomics Malaysia, emphasized that the facility, equipped with advanced multi-platform sequencing and a dedicated expert team, will empower local partners to build capabilities and accelerate scientific and clinical progress throughout Asia Pacific. Guests at the launch experienced an immersive tour of the laboratory, observing operational workflows from sample processing and sequencing to data analysis, highlighting Yikon’s rigorous quality control and transparent approach to clinical collaboration. Central to Yikon’s innovation is its proprietary MALBAC (Multiple Annealing and Loop-Based Amplification Cycles) technology, which enables the detection of ultra-small quantities of genetic material and powers applications ranging from embryo testing to hereditary disease screening and oncology diagnostics.
By integrating MALBAC into a comprehensive reproductive genetics ecosystem, Yikon ensures accurate, reliable, and personalized results, enabling families to make informed healthcare decisions while advancing fertility and genomics standards across the region. Dr. Lu also emphasized the laboratory’s role as a regional hub for collaboration, supporting fertility centers, local laboratories, and preventive healthcare initiatives. The new Kuala Lumpur facility will serve as both a service and reference center for Asia Pacific, fostering partnerships with hospitals, research institutions, and clinical centers to accelerate the adoption of precision medicine and preventive healthcare solutions. Concluding the event, Dr. Lu expressed optimism about Malaysia’s growing focus on genomics and preventive healthcare, stating, “Healthcare of the future depends on prevention, not just treatment. With our Malaysian lab, we are one step closer to enabling healthier families, stronger communities, and a sustainable healthcare system for generations to come.”
